Literature DB >> 15282364

Transient improvement of spinocerebellar ataxia with zolpidem.

Ralf Clauss, Mike Sathekge, Wally Nel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282364     DOI: 10.1056/NEJM200407293510522

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  High-dose zolpidem withdrawal seizure in a patient with spinocerebellar ataxia.

Authors:  Cheng-Chen Chang; Wen-Fang Wang
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.

Authors:  Jenny Lam; Nichole Coleman; April Lourdes A Garing; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

Review 3.  Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?

Authors:  Rosella Ciurleo; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

4.  Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.

Authors:  Stephanie C Licata; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-30       Impact factor: 5.067

Review 5.  Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs?

Authors:  Francesca Pistoia; Elisa Mura; Stefano Govoni; Massimo Fini; Marco Sarà
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

6.  Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.

Authors:  Nupur Nag; Volga Tarlac; Elsdon Storey
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

Review 7.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

8.  Transient improvement of poststroke apathy with zolpidem: a single-case, placebo-controlled double-blind study.

Authors:  Katell Autret; Annabelle Arnould; Sarah Mathieu; Philippe Azouvi
Journal:  BMJ Case Rep       Date:  2013-02-08

Review 9.  Treatment Options in Degenerative Cerebellar Ataxia: A Systematic Review.

Authors:  Harini Sarva; Vicki Lynn Shanker
Journal:  Mov Disord Clin Pract       Date:  2014-06-12

10.  Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy.

Authors:  Andrew Young Chang; Erica Weirich
Journal:  Case Rep Med       Date:  2014-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.